Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies Graux, Carlos; Sonet, Anne; Maertens, Johan; Duyster, Justus; ... Ottmann, Oliver G 2013
add to browser selection
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis Robin, Marie-Claude; Chevret, Sylvie; Koster, Linda; Wolschke, Christine; ... Kröger, Nicolaus 2019
add to browser selection
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse Kharfan-Dabaja, Mohamed A; Labopin, Myriam; Polge, Emmanuelle; Nishihori, Taiga; ... Mohty, Mohamad 2018
add to browser selection
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study Terwijn, Monique; van Putten, Wim L J; Kelder, Angèle; van der Velden, Vincent H J; ... Schuurhuis, Gerrit J 2013
add to browser selection
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome Robinson, Stephen P.; Sureda, Anna; Canals, Carmen; Russell, Nigel; ... Schmitz, Norbert 2009
add to browser selection
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML. Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; van Norden, Yvette; ... Ossenkoppele, Gert J 2017